Literature DB >> 24510293

A mouse model of foodborne Listeria monocytogenes infection.

Elsa N Bou Ghanem1, Tanya Myers-Morales1, Sarah E F D'Orazio1.   

Abstract

Listeria monocytogenes causes foodborne disease in humans that ranges in severity from mild, self-limiting gastroenteritis to life-threatening systemic infections of the blood, brain, or placenta. The most commonly used animal model of listeriosis is intravenous infection of mice. This systemic model is highly reproducible, and thus, useful for studying cell-mediated immune responses against an intracellular bacterial pathogen, but it completely bypasses the gastrointestinal phase of L. monocytogenes infection. Intragastric inoculation of L. monocytogenes produces more variable results and may cause direct bloodstream invasion in some animals. The foodborne transmission model described here does not require specialized skills to perform and results in infections that more closely mimic human disease. This natural feeding model can be used to study both the host- and pathogen-derived factors that govern susceptibility or resistance to orally acquired L. monocytogenes.
Copyright © 2013 John Wiley & Sons, Inc.

Entities:  

Keywords:  intestines; intracellular pathogen; listeriosis; oral transmission

Mesh:

Year:  2013        PMID: 24510293      PMCID: PMC4191863          DOI: 10.1002/9780471729259.mc09b03s31

Source DB:  PubMed          Journal:  Curr Protoc Microbiol        ISSN: 1934-8525


  14 in total

1.  Enrichment of Neutrophils and Monocytes From the Liver Following Either Oral or Intravenous Listeria monocytogenes Infection.

Authors:  Michelle G Pitts; Sarah E F D'Orazio
Journal:  Curr Protoc Immunol       Date:  2020-09

2.  Prostaglandin E2 Inhibits the Ability of Neutrophils to Kill Listeria monocytogenes.

Authors:  Michelle G Pitts; Sarah E F D'Orazio
Journal:  J Immunol       Date:  2019-05-06       Impact factor: 5.422

3.  Neutrophils from Both Susceptible and Resistant Mice Efficiently Kill Opsonized Listeria monocytogenes.

Authors:  Michelle G Pitts; Travis A Combs; Sarah E F D'Orazio
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

4.  Monocytes Are the Predominant Cell Type Associated with Listeria monocytogenes in the Gut, but They Do Not Serve as an Intracellular Growth Niche.

Authors:  Grant S Jones; Sarah E F D'Orazio
Journal:  J Immunol       Date:  2017-02-17       Impact factor: 5.422

5.  Contaminated water delivery as a simple and effective method of experimental Salmonella infection.

Authors:  Hope O'Donnell; Oanh H Pham; Joseph M Benoun; Marietta M Ravesloot-Chávez; Stephen J McSorley
Journal:  Future Microbiol       Date:  2015-10-06       Impact factor: 3.165

6.  Type I IFN Does Not Promote Susceptibility to Foodborne Listeria monocytogenes.

Authors:  Michelle G Pitts; Tanya Myers-Morales; Sarah E F D'Orazio
Journal:  J Immunol       Date:  2016-02-19       Impact factor: 5.422

7.  Intracellular Listeria monocytogenes comprises a minimal but vital fraction of the intestinal burden following foodborne infection.

Authors:  Grant S Jones; Kate M Bussell; Tanya Myers-Morales; Abigail M Fieldhouse; Elsa N Bou Ghanem; Sarah E F D'Orazio
Journal:  Infect Immun       Date:  2015-05-26       Impact factor: 3.441

8.  Listeria monocytogenes Replicate in Bone Marrow-Derived CD11c+ Cells but Not in Dendritic Cells Isolated from the Murine Gastrointestinal Tract.

Authors:  Grant S Jones; Victoria C Smith; Sarah E F D'Orazio
Journal:  J Immunol       Date:  2017-10-20       Impact factor: 5.422

9.  Comparison between Listeria sensu stricto and Listeria sensu lato strains identifies novel determinants involved in infection.

Authors:  Jakob Schardt; Grant Jones; Stefanie Müller-Herbst; Kristina Schauer; Sarah E F D'Orazio; Thilo M Fuchs
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

10.  Route of Injection Affects the Impact of InlB Internalin Domain Variants on Severity of Listeria monocytogenes Infection in Mice.

Authors:  Konstantin A Sobyanin; Elena V Sysolyatina; Yaroslava M Chalenko; Egor V Kalinin; Svetlana A Ermolaeva
Journal:  Biomed Res Int       Date:  2017-12-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.